Effect of industrial solvent exposure on blood pressure and liver ultrasound echogenicity

Scandinavian Journal of Work, Environment and Health, Supplement

Volumn , Issue 2, 2006, Pages 54-60

  Kaukiainen, Ari ^a   Martikainen, Rami ^a   Luoma, Katariina ^b   Taskinen, Helena ^a,c   Helin, Karri ^d   Vehmas, Tapio ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HYVINKÄÄ HOSPITAL   (Finland)

Author keywords

Alcohol; Blood pressure; Fatty liver; Occupational exposure; Solvents; Ultrasonography

Indexed keywords

ACETIC ACID DERIVATIVE; ALCOHOL; ALIPHATIC COMPOUND; ETHER DERIVATIVE; HALOGENATED HYDROCARBON; KETONE; SOLVENT; TOLUENE; XYLENE;

BLOOD; HEALTH RISK; MEDICAL GEOGRAPHY; OCCUPATIONAL EXPOSURE; RISK FACTOR; SOLVENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; BLOOD PRESSURE MEASUREMENT; BODY MASS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ECHOGRAPHY; FATTY LIVER; FEMALE; GENDER; HUMAN; HYPERTENSION; LONG TERM EXPOSURE; MALE; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ALCOHOL DRINKING; BLOOD PRESSURE; BODY MASS INDEX; CONFOUNDING FACTORS (EPIDEMIOLOGY); FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; SOLVENTS;

EID: 33751061885     PISSN: 03566528     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Kaplan NM. Alcohol and hypertension. Lancet. 1995;345:1588-9.
2. Klatsky AL. Alcohol and cardiovascular disease - more than one paradox to consider. Alcohol and hypertension: does it matter? Yes. J Cardiovasc Risk. 2003;10:21-4.
3. Kotseva K, Popov T. Study of the cardiovascular effects of occupational exposure to organic solvents. Int Arch Occup Environ Health. 1998;71 Suppl:S87-91.
4. Kaukiainen A, Riala R, Martikainen R, Akila R, Reijula K, Sainio M. Solvent-related health effects among construction painters with decreasing exposure. Am J Ind Med. 2004; 46:627-36.
5. Wilcosky TC, Simonsen NR. Solvent exposure and cardiovascular disease. Am J Ind Med. 1991;19:569-86.
6. Xiao JQ, Levin SM. The diagnosis and management of solvent-related disorders. Am J Ind Med. 2000;37:44-61.
7. Semple S. Dermal exposure to chemicals in the workplace: just how important is skin absorption? Occup Environ Med. 2004;61:376-82.
8. Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med. 2001;250:105-20.
9. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome: diabetes. 2001;50:1844-50.
10. Kaukiainen A, Vehmas T, Rantala K, Nurminen M, Martikainen R, Taskinen H. Results of common laboratory tests in solvent-exposed workers. Int Arch Occup Environ Health. 2004;77:39-46.
11. Lundqvist G, flodin U, Axelson O. A case-control study of fatty liver disease and organic solvent exposure. Am J Ind Med. 1999;35:132-6.
12. Mathiesen UL, Franzen LE, Aselius H, Resjo M, Jacobsson L, Foberg U, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34:516-22.
13. Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med. 2002;21:1023-32.
14. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med.
15. Gordon AJ, Maisto SA, McNeil M, Kraemer KL, Conigliaro RL, Kelley ME, et al. Three questions can detect hazardous drinkers. J Fam Pract. 2001;50:313-20.
16. Brodkin CA, Daniell W, Checkoway H, Echeverria D, Johnson J, Wang K, et al. Hepatic ultrasonic changes in workers exposed to perchloroethylene. Occup Environ Med. 1995;52:679-85.
17. Vehmas T, Kaukiainen A, Luoma K, Lohman M, Nurminen M, Taskinen H. Liver echogenicity: measurement or visual grading? Comput Med Imaging Graph. 2004;28:289-93.
18. Pickering TG. Blood pressure measurement and detection of hypertension. Lancet. 1994;344:31-5.
19. Lindbaek M, Sandvik E, Liodden K, Mjell J, Ravnsborg-Gjertsen K. Predictors for the white coat effect in general practice patients with suspected and treated hypertension. Br J Gen Pract. 2003;53:790-3.
20. Baker EL. A review of recent research on health effects of human occupational exposure to organic solvents: a critical review. J Occup Med. 1994;36:1079-92.
21. Matanoski GM, Tao XG. Styrene exposure and ischemic heart disease: a case-cohort study. Am J Epidemiol. 2003;158:988-95.
22. Hewitt JB, Tellier L. Risk of adverse outcomes in pregnant women exposed to solvents. J Obstet Gynecol Neonatal Nurs. 1998;27:521-31.
23. Eskenazi B, Bracken MB, Holford TR, Grady J. Exposure to organic solvents and hypertensive disorders of pregnancy. Am J Ind Med. 1988;14:177-88.
24. Suadicani P, Hein HO, Gyntelberg F. Do physical and chemical working conditions explain the association of social class with ischaemic heart disease? Atherosclerosis. 1995;113:63-9.
25. Widdicombe J, Lee LY. Airway reflexes, autonomic function, and cardiovascular responses. Environ Health Perspect. 2001;109 Suppl 4:579-84.
26. Yeates DB, Mauderly JL. Inhaled environmental/occupational irritants and allergens: mechanisms of cardiovascular and systemic responses: introduction. Environ Health Perspect. 2001;109 Suppl 4:479-81.
27. Sjögren B. Occupational exposure to air pollutants, inflammation and ischemic heart disease. Scand J Work Environ Health. 2004;30:421-3.
28. Steinhauer SR, Morrow LA, Condray R, Scott AJ. Respiratory sinus arrhythmia in persons with organic solvent exposure: comparisons with anxiety patients and controls. Arch Environ Health. 2001;56:175-80.
29. Matikainen E, Juntunen J. Autonomic nervous system dysfunction in workers exposed to organic solvents. J Neurol Neurosurg Psychiatry. 1985;48:1021-4.
30. Rutchik JS, Wittman RI. Neurologic issues with solvents. Clin Occup Environ Med. 2004;4:621-56, v-vi.
31. MacDonald AJ, Rostami-Hodjegan A, Tucker GT, Linkens DA. Analysis of solvent central nervous system toxicity and ethanol interactions using a human population physiologically based kinetic and dynamic model. Regul Toxicol Pharmacol. 2002;35:165-76.
32. Lundberg I, Nise G, Hedenborg G, Högberg M, Vesterberg O. Liver function tests and urinary albumin in house painters with previous heavy exposure to organic solvents. Occup Environ Med. 1994;51:347-53.
33. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 1988;27:142-9.
34. Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol. 2003;9:1106-10.
35. Akahoshi M, Amasaki Y, Soda M, Tominaga T, Ichimaru S, Nakashima E, et al. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. Hypertens Res. 2001;24:337-43.
36. Vehmas T, Kaukiainen A, Immonen-Räihä P, Lohman M, Luoma K. Liver echogenicity: relation to systemic blood pressure and other components of the metabolic syndrome. Ultrasound Med Biol. 2005;31:293-9.
37. James OF, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol. 1998;29:495-501.
38. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord. 1995;19:846-50.
39. Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol. 1996;7:217-26.